Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 3, 2008, Pages 348-350

  Iqbal, Naureen J ^a   Boey, Angeline ^a   Park, Benjamin J ^a   Brandt, Mary E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

E test; Fusarium spp.; Keratitis

Indexed keywords

AMPHOTERICIN B; ECHINOCANDIN; ITRACONAZOLE; NATAMYCIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; EPSILOMETER TEST; FUNGAL STRAIN; FUNGUS ISOLATION; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; EYE INFECTIONS, FUNGAL; FUSARIUM; HUMANS; KERATITIS; LABORATORIES; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; TRIAZOLES;

EID: 53949117202     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.07.003     Document Type: Article

References (23)

1. Alastruey-Izquierdo A., Cuenca-Estrella M., Monzón A., Mellado E., and Rodríguez-Tudela J.L. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J. Antimicob. Chemother. 61 (2008) 805-809
2. Azor M., Gené J., Cano J., and Guarro J. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob. Agents Chemother. 51 (2007) 1500-1503
3. Azor M., Gené J., Cano J., Sutton D.A., Fothergill A.W., Rinaldi M.G., and Guarro J. In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. Antimicrob. Agents Chemother. 52 (2008) 2228-2231
4. Chang D.C., Grant G.B., O'Donnell K., Wannemuehler K.A., Noble-Wang J., Rao C.Y., Jacobson L.M., Crowell C.S., Sneed R.S., Lewis F.M.T., Schaffzin J.K., Kainer M.A., Genese C.A., Alfonso E.C., Jones D.B., Srinivasan A., Fridkin S.K., and Park B.J. Multistate outbreak of Fusarium keratitis associated with use of contact lens solution. JAMA 296 (2006) 953-963
5. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard CLSI document M38-A2 (2008), Clinical and Laboratory Standards Institute, Wayne, PA
6. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH 56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36 (1998) 2950-2956
7. Espinel-Ingroff A., Fothergill A., Ghannoum M., Manavathu E., Ostrosky-Zeichner L., Pfaller M., Rinaldi M., Schell W., and Walsh T.J. Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. J. Clin. Microbiol. 45 (2007) 2180-2182
8. Hariprasad S.M., Mieler W.F., Lin T.K., Sponsel W.E., and Graybill J.R. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br. J. Ophthalmol. 92 (2008) 871-876
9. Isham N., and Ghannoum M.A. Determination of MIC of aminocandin for Candida spp. and filamentous fungi. J. Clin. Microbiol. 44 (2006) 4342-4344
10. Iyer S.A., Tuli S.S., and Wagoner R.C. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens 32 (2006) 267-271
11. Lalitha P., Shapiro B.L., Srinivasan M., Prajna N.V., Acharya N.R., Fothergill A.W., Ruiz J., Chidambaram J.D., Maxey K.J., Hong K.C., McLeod S.D., and M Lietman T. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol. 125 (2007) 789-793
12. Marangon F.B., Miller D., Giaconi J.A., and Alfonso E.C. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am. J. Ophthalmol. 137 (2004) 820-825
13. O'Donnell K., Sarver B.A., Brandt M., Chang D., Noble-Wang J., Park B.J., Sutton D.A., Benjamin L., Lindsley M., Padhye A., Geiser D.M., and Ward T.J. Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J. Clin. Microbiol. 45 (2007) 2235-2248
14. O'Donnell K., Sutton D.A., Fothergill A., Mc Carthy D., Rinaldi M.G., Brandt M.E., Zhang N., and Geiser D.M. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J. Clin. Microbiol. 46 (2008) 2477-2490
15. Paphitou N.I., Ostrosky-Zeichner L., Paetznick V.L., Rodriguez J.R., Chen E., and Rex J.R. In vitro activities of investigational triazole against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob. Agents Chemother. 46 (2002) 3298-3300
16. Pfaller M.A., Messer S.A., Hollis R.J., Jones R.N., and and the Sentry participants group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program, 2000. Antimicrob. Agents Chemother. 46 (2002) 1032-1037
17. Rex J.H., Pfaller M.A., Walsh T.J., Chaturvedi V., Espinel-Ingroff A., Ghannoum M.A., Gosey L.L., Odds F.C., Rinaldi M.G., Sheehan D.J., and Warnock D.W. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 4 (2001) 643-658
18. Sponsel W.E., Graybill J.R., Nevarez H.L., and Dang D. Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br. J. Ophthalmol. 84 (2002) 829-830
19. Tortorano A.M., Prigitano A., Dho G., Esposto M.C., Gianni C., Grancini A., Ossi C., and Viviani M.A. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from Northern Italy. Antimicrob. Agents Chemother. 52 (2008) 2683-2685
20. Tu E.Y., McCartney D.L., Beatty R.F., Springer K.L., Levy J., and Edward D. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am. J. Ophthalmol. 143 (2007) 222-227
21. Verma S., and Tuft S.J. Fusarium solani keratitis following LASIK for myopia. Br. J. Ophthalmol. 86 (2002) 1190-1191
22. Xie L., Zhai H., Zhao J., Sun S., Shi S., and Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong province, China. Am. J. Ophthalmol. 146 (2008) 260-265
23. Xuguang S., Zhixin W., Zhiqun W., Shiyun L., and Ran L. Ocular fungal isolates and antifungal susceptibility in Northern China. Am. J. Ophthalmol. 143 (2007) 131-133